Technological advancements coupled with R&D initiatives in healthcare services have led to the development of biological implants developed from cultures of pre existing cell samples. They are either purely biological in nature, comprising implantable ex situ cultured tissue or are a hybrid of cell culture combined with bio-materials such as polymers, titanium or gold alloys. The compositions of the implants depend upon the specific regenerative capacity, immunogenicity or biomechanical strength required to treat the damaged organ or tissue.
Full research report on Global Biological Implants Market with detailed figures and charts available at: http://www.grandviewresearch.com/industry-analysis/biological-implants-market
Soft tissue, cardiovascular, dental, orthopedic, dental, urologic and ophthalmic implants are the application areas of biological implants market. Segmentation on the basis of origin divides them into autografts (implant material extracted from the same individual), allografts (implant material extracted from different individual of the same species) and xenograft (implant material extracted from other species, mainly bovine or porcine in nature). The largest segment is occupied by the cardiovascular implants owing to the fact that allograft heart valve and artery/vein reconstructions have met with significant success in reducing implant rejection rates and increase post surgical survival rates.
Get more information on Global Biological Implants Market or request for TOC of this research report at: http://www.grandviewresearch.com/industry-analysis/biological-implants-market/request-toc
North America emerged as the most revenue contributing region due to the growing prevalence of diseases which require intervention procedures using biological implants combined with the advancements of healthcare technologies in the region. Asia Pacific is expected to grow at a lucrative CAGR for the estimated period. Presence of high unmet medical needs coupled with favorable government initiatives is major driver contributing for its growth. The key players analyzed in the report include Aastrom Biosciences Inc., IOP Inc., Maxigen Biotech Inc., CryoLife Inc., Pioneer Surgical Technologies, LifeCell Corporation, NuVasive Inc., Integra Lifescience Corporation, Edwards LifeSciences Corporation, Pegasus Biologics Inc., Stryker Corporation, Allergan Inc., Arthro-Kinetics Plc, Tutogen Medical Inc., Asterand Plc, BioTissue Technologies AG and CR Bard Inc.
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information, visit - http://www.grandviewresearch.com/
Blog - http://www.divog.org/
Media ContactCompany Name: Grand View Research, Inc.
Contact Person: Sherry James
Email:Send Email
Phone: 1-415-349-0058
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/biological-implants-market
